2019
 
2015
2016
2017
2018
2019
 
2019
 


My subsidiary won Private Technology Corporate in Jiangsu Province.
 
Aug.18th,2019—Nanjing, China—Adhering to the "Innovation as dynamics, differentiation as core" business philosophy and being committed to providing differentiated products with intellectual property solutions and environmentally friendly chemical technology to global customers by comprehensive research and development capabilities, Nanjing F&S PharmaTech Co., Ltd. (hereinafter referred to as F&S) announced that Nanjing Yixinhe Pharmatech Co., Ltd. (hereinafter referred to as Nanjing Yixinhe), the holding subsidiary of F&S, won Private Technology Corporate in Jiangsu Province recently.

Nanjing Yixinhe is a joint venture which had been invested RMB 30 million by F&S and Guangdong Yixin Pharmaceutical Co., Ltd in April 2016. Facing the spring tide of the domestic healthcare reform, Nanjing Yixinhe is committed to R&D and commercialized production of differentiated products by combining the policy advantages, and make great efforts to bring good medicines for people earlier.
In October 2018, Nanjing Yixinhe firstly declared Entresto in China, which attracted much attention in the industry.
Nanjing Yixinhe won awards again, which is after Technological Small and Medium-sized Enterprises in May 2018.

About Guangdong Yixin Pharmaceutical Co., Ltd.
Founded in Feb. 2001, and headquartered in Guangzhou, Guangdong Yixin Pharmaceutical Co., Ltd. (hereinafter referred to as Guangdong Yixin) is an innovation oriented private enterprise, which integrates R&D and sales of drugs. Guangzhou Yixin has already passed the GSP certification, and has a sound sales network and mature marketing channels. The company owed two state first class drugs, the market share and the coverage rate of their products are in leading position in the like products. Guangzhou Yixin has established a highly professional brand and popularity among the domestic clinicians and patients.

About Nanjing F&S Pharmatech Co., Ltd.
Founded in Oct. 2015 and has completed three rounds of financing, which won National High-tech Enterprise, Fostering Unicorn Enterprises in Nanjing and the first batch of "Little Lark" Enterprises in Jiangbei New Area of Nanjing. We have 5000 square meters of R&D center and have established a comprehensive in-depth cooperation with Jiangsu Yongda Pharmaceutical Co., Ltd.

For more information of Nanjing F&S Pharmatech Co., Ltd., please visit company website: www.fshpharm.com.
 
 
Copyright © 2014-2015 DEDECMS 方生和医药科技有限公司 版权所有
网站开发:希丁哥